Adult Psychiatry for Growth Need - Multiple Locations

TMS Solutions is seeking BE/BC Adult Psychiatrists for multiple locations throughout the western United States.  We are expanding our operations and adding more clinics, providing an excellent opportunity for psychiatrists that are passionate about transforming the lives of those who suffer from depression.  Here are just a few highlights:

• No Call
• Flexible Schedule
• Great source of secondary income
• State of the art technology 
• Excellent support staff
• Patient remission rates greater than 50% and response rates greater than 80%
• 9 Locations - Arizona, Colorado, Idaho, Montana, Oregon, Utah, Washington, Wyoming

TMS Solutions is passionate about transforming the lives of those who suffer from depression through TMS Therapy.

Like the pillars of the Temple of Athena, the following strengths support the foundation our company was built upon.

1. Saving Lives: In the darkness of depression, a flicker of light is hope. The possibility of a new beginning, and of life renewed.
2. Connection: We stimulate healing through connection, both neural and human. Together, they are stronger.
3. Leadership: Through educating ourselves, teaching new providers, and becoming an authority in the field, we will help facilitate a movement toward progress. The growth of a new promise.
4. Unwavering Passion: When passion meets purpose, anything is possible.
5. Veteran Advocacy: Veterans fought to protect our freedoms - let’s make it our mission to help them pick up the pieces.
6. Spreading the Message: TMS can help so many. By raising awareness for TMS therapy, we help create a new standard of care.

TMS Solutions has developed a business model that is becoming the market leader in providing Transcranial Magnetic Stimulation Therapy for the treatment of Major Depressive Disorder.  Based in Colorado, and operating 18 devices in Colorado, Wyoming, Utah, Idaho and Washington, we are a privately held company focused primarily on treating patients with MDD and treatment-resistant depression (TRD).  We are currently utilizing the first commercially-developed TMS technology to receive FDA approval for the treatment of MDD.  This FDA indication is for a non-systemic and non-invasive depression treatment for patients who have not benefited from prior antidepressant medication.  This system, the CloudNeuro TMS Therapy System, is currently being used throughout the United States and in select markets around the world.